Skip to content
10-K

Annual Report

AMYLIN PHARMACEUTICALS INC

0001193125-12-072788

← back to feed
Filed
Feb 22, 2012 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2011 · Feb 16, 2012 147.3M sh
Capex FY 2011 · Dec 31, 2011 $54.45M
Capex FY 2011 · Dec 31, 2010 $91.13M
Capex FY 2011 · Dec 31, 2009 $152.05M
Operating Cash Flow FY 2011 · Dec 31, 2011 $88.3M
Operating Cash Flow FY 2011 · Dec 31, 2010 −$38.72M
Operating Cash Flow FY 2011 · Dec 31, 2009 $19.92M
Short Term Debt FY 2011 · Dec 31, 2011 $63.55M
Short Term Debt FY 2011 · Dec 31, 2010 $200M
Cash And Equivalents FY 2011 · Dec 31, 2011 $99.86M
Cash And Equivalents FY 2011 · Dec 31, 2010 $164.52M
Cash And Equivalents FY 2011 · Dec 31, 2009 $120.83M
Cash And Equivalents FY 2011 · Dec 31, 2008 $237.26M
Stockholders Equity FY 2011 · Dec 31, 2011 −$138.75M
Stockholders Equity FY 2011 · Dec 31, 2010 $343.48M
Stockholders Equity FY 2011 · Dec 31, 2009 $422.53M
Stockholders Equity FY 2011 · Dec 31, 2008 $519.28M
Current Liabilities FY 2011 · Dec 31, 2011 $296.02M
Current Liabilities FY 2011 · Dec 31, 2010 $401.6M
Current Assets FY 2011 · Dec 31, 2011 $421.19M
Current Assets FY 2011 · Dec 31, 2010 $676.4M
Total Assets FY 2011 · Dec 31, 2011 $1.87B
Total Assets FY 2011 · Dec 31, 2010 $1.53B
Sga Expense FY 2011 · Dec 31, 2011 $271.22M
Sga Expense restated FY 2011 · Dec 31, 2010 $276.88M
Sga Expense restated FY 2011 · Dec 31, 2009 $330.49M
Rd Expense FY 2011 · Dec 31, 2011 $161.22M
Rd Expense restated FY 2011 · Dec 31, 2010 $183.08M
Rd Expense restated FY 2011 · Dec 31, 2009 $198.44M
Net Income FY 2011 · Dec 31, 2011 −$461.47M
Net Income FY 2011 · Dec 31, 2011 −$543.4M
Net Income FY 2011 · Sep 30, 2011 −$13.2M
Net Income FY 2011 · Jun 30, 2011 −$31.41M
Net Income FY 2011 · Mar 31, 2011 −$37.32M
Net Income FY 2011 · Dec 31, 2010 −$19.18M
Net Income FY 2011 · Dec 31, 2010 −$152.31M
Net Income FY 2011 · Sep 30, 2010 −$50.73M
Net Income FY 2011 · Jun 30, 2010 −$44.2M
Net Income FY 2011 · Mar 31, 2010 −$38.2M
Net Income FY 2011 · Dec 31, 2009 −$186.26M
Operating Income FY 2011 · Dec 31, 2011 −$491.46M
Operating Income FY 2011 · Dec 31, 2010 −$126.74M
Operating Income FY 2011 · Dec 31, 2009 −$173.35M
Gross Profit FY 2011 · Dec 31, 2011 $148.55M
Gross Profit FY 2011 · Sep 30, 2011 $143.4M
Gross Profit FY 2011 · Jun 30, 2011 $142.95M
Gross Profit FY 2011 · Mar 31, 2011 $138.3M
Gross Profit FY 2011 · Dec 31, 2010 $148.27M
Gross Profit FY 2011 · Sep 30, 2010 $141.35M
Gross Profit FY 2011 · Jun 30, 2010 $148.05M
Gross Profit FY 2011 · Mar 31, 2010 $151.76M
Cost Of Revenue FY 2011 · Dec 31, 2011 $48.38M
Cost Of Revenue FY 2011 · Dec 31, 2010 $61.69M
Cost Of Revenue FY 2011 · Dec 31, 2009 $83M
Revenue FY 2011 · Dec 31, 2011 $650.68M
Revenue FY 2011 · Dec 31, 2010 $668.81M
Revenue FY 2011 · Dec 31, 2009 $758.42M